The episode covers Nvidia's record $96.2B quarterly revenue and $60B profit, dismissing the AI CapEx bubble narrative, while Salesforce's rebound signals the SaaS apocalypse was overdone. The hosts debate Treasury Secretary Bessent's bond-buyback strategy versus Druckenmiller's critique, arguing only Congress can fix America's $40T debt and $2.5T annual deficit. A segment on a promising cancer vaccine (neoantigen therapy) raises questions about pricing and regulatory capture, noting the process could be made widely available at low cost.
Summarized by Podsumo
Nvidia posted $96.2B quarterly revenue (up 106% YoY) and $60B net profit—the most profitable core business quarter ever—with guidance for 70% growth, dismissing AI CapEx bubble fears.
Salesforce rebounded 20%+ after integrating AI, proving horizontal SaaS platforms like CRM are complementary to agents, not doomed to replacement.
Treasury Secretary Bessent's bond buybacks drew criticism from mentor Druckenmiller, who argued only Congress can fix the $40T debt and $2.5T annual deficit, not market interventions.
America faces a fiscal crisis: the 30-year Treasury at 5.2%, a $10T refinancing wave in 12 months, and risk of a death spiral if yields hit 6%—with Social Security insolvency projected by 2030-2032.
Moderna's cancer vaccine (neoantigen therapy) uses personalized mRNA to train the immune system to attack tumors; the hosts question whether the process—developed with public funding—should be patented and priced at $500K when cheaper alternatives exist.
"If you adopt the technology, you survive; if you don't, you die. It's pretty straightforward."
"The bond market is going to start to do this [force Congress to act] because that single price is the true reflection of the good faith and trust in the United States."
"That 70% number would have been higher, but they said they were supply constrained."